ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.751,05
0,66%
S&P 500
5.633,09
0,13%
Dow Jones
41.622,08
0,00%
Euro vs US Dollar
1,11377
0,08%
Bitcoin
59.090,40
1,55%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Ardelyx Inc (ARDX)

  7. Ardelyx Inc (ARDX) News

ARDX

Ardelyx (ARDX)

Ardelyx Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ARDX
DatumZeitQuelleÜberschriftSymbolFirma
17/09/202400h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
16/09/202411h45PR Newswire (US)Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact The Gross Law Firm about pending Class Action - ARDXNASDAQ:ARDXArdelyx Inc
12/09/202411h45PR Newswire (US)Ardelyx, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 15, 2024 to Discuss Your Rights - ARDXNASDAQ:ARDXArdelyx Inc
09/09/202411h45PR Newswire (US)Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ARDXArdelyx Inc
05/09/202414h00GlobeNewswire Inc.Ardelyx to Participate at the 2024 Cantor Global Healthcare ConferenceNASDAQ:ARDXArdelyx Inc
05/09/202411h45PR Newswire (US)ARDX LAWSUIT ALERT: The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:ARDXArdelyx Inc
29/08/202411h45PR Newswire (US)Ardelyx, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 15, 2024 to Discuss Your Rights - ARDXNASDAQ:ARDXArdelyx Inc
26/08/202422h49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARDXArdelyx Inc
26/08/202411h45PR Newswire (US)Class Action Filed Against Ardelyx, Inc. (ARDX) - October 15, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:ARDXArdelyx Inc
23/08/202400h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
23/08/202400h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
23/08/202400h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
23/08/202400h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
23/08/202400h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
22/08/202411h45PR Newswire (US)Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:ARDXArdelyx Inc
22/08/202411h45PR Newswire (US)Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:ARDXArdelyx Inc
21/08/202400h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
17/08/202400h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
17/08/202400h08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
16/08/202422h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARDXArdelyx Inc
12/08/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
08/08/202414h00GlobeNewswire Inc.Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial OfficerNASDAQ:ARDXArdelyx Inc
01/08/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARDXArdelyx Inc
01/08/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
01/08/202422h01GlobeNewswire Inc.Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARDXArdelyx Inc
31/07/202414h02GlobeNewswire Inc.Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and OpinionNASDAQ:ARDXArdelyx Inc
18/07/202414h00GlobeNewswire Inc.Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024NASDAQ:ARDXArdelyx Inc
17/07/202423h10GlobeNewswire Inc.Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful MedicinesNASDAQ:ARDXArdelyx Inc
02/07/202413h00GlobeNewswire Inc.To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPANASDAQ:ARDXArdelyx Inc
28/06/202414h17GlobeNewswire Inc.Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare DisciplinesNASDAQ:ARDXArdelyx Inc
 Showing the most relevant articles for your search:NASDAQ:ARDX

Kürzlich von Ihnen besucht

TG
BAS
BASF
CCOM
US500
US 500
USOTC
RHHBY
Roche (QX)
CCOM
US30
US 30
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
TG
BAYN
Bayer
TG
LHA
Deutsche Lufthansa
NYSE
MRK
Merck
COIN
XRPUSD
Ripple
COIN
DOGEUSD
Dogecoin
TG
MBG
MercedesBenz
NASDAQ
AMZN
Amazon.com
AMEX
XLV
Health Care Select Sector
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten